NKTX
Nkarta, Inc.
$3.22
+0.37 (+12.98%)
At close · Jul 2
Market Cap
$230.38M
Shares
71,545,358
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $2,978,038 |
| Nadir Mahmood | — | $1,396,007 |
| Shawn Rose | — | $1,224,773 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $3,985,445 |
| Nadir Mahmood | — | $3,336,117 |
| David Shook | — | $1,900,182 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $2,934,715 |
| David Shook | — | $1,510,050 |
| Alyssa Levin | — | $1,286,958 |
| Nadir Mahmood | — | $820,145 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $4,744,750 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $6,775,031 |
| Dr. Kanya Rajangam | — | $2,590,983 |
| Dr. Nadir | — | $2,548,843 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dr. Matthew | — | $3,871,766 |
| Dr. Alicia Hager | — | $3,279,966 |
| Paul J. Hastings | CEO | $3,180,446 |
| Dr. Nadir | — | $2,374,379 |
| Dr. Kanya Rajangam | — | $1,418,306 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Paul J. Hastings | CEO | $2,870,145 |
| Former Chief | — | $1,056,798 |